12,741 results on '"Lung Diseases, Interstitial"'
Search Results
2. Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
3. Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)
4. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)
5. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
6. REBUILD-SM Study for People With Interstitial Lung Disease (ILD)
7. A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis
8. Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension (SAPPHIRE)
9. Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit (O2LUSSU)
10. Effects of Tofacitinib vs Methotrexate on Rheumatoid Arthritis Interstitial Lung Disease (PULMORA)
11. An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
12. Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
13. A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
14. A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
15. Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
16. The Edinburgh Lung Fibrosis Molecular Endotyping (ELFMEN) Study (ELFMEN)
17. Myositis Interstitial Lung Disease Nintedanib Trial (MINT)
18. Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.
19. FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion (FIBRINOX-EXTRA)
20. A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
21. Skeletal Muscle Function in Interstitial Lung Disease
22. Reducing Disparities in the Quality of Advance Care Planning for Older Adults (EQUALACP)
23. Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)
24. PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT (PREDICT-ILD)
25. Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers (PICSI-M)
26. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
27. INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation (INREAL)
28. Hydroxychloroquin (HCQ) in chILD of Genetic Defect
29. Japanese Idiopathic Interstitial Pneumonias Registry (JIPS)
30. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
31. Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases
32. Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
33. Hiatal Hernia and Pulmonary Involvement
34. University of Virginia Natural History Study
35. The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. (iNO)
36. Ultrasound and Respiratory Physiological Signals in Lung Diseases (SAURON)
37. Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD)
38. A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE) (iLiFE)
39. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)
40. Aerobic Exercise in Patients With Pulmonary Hypertension
41. FAPI PET for Lung Fibrosis (FAPI ILD)
42. Genentech Validation Tool for Pulmonary Fibrosis
43. LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease (SUNSET)
44. A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)
45. Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis (HALT-IPF)
46. Epidemiology of Surfactant Protein-B Deficiency
47. Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases
48. Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
49. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients
50. Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.